Catalyst Funds Management’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.8K Buy
+21,824
New +$59.5K 0.01% 538
2025
Q2
Sell
-11,238
Closed -$30.3K 547
2025
Q1
$30.3K Buy
+11,238
New +$42.2K 0.01% 429
2024
Q4
Sell
-4,800
Closed -$11.4K 722
2024
Q3
$11.4K Hold
4,800
﹤0.01% 1167
2024
Q2
$9.36K Buy
+4,800
New +$16.3K ﹤0.01% 944

Other funds holding GNLX

Catalyst Funds Management's GNLX Position: Q1 2026 in Review

Catalyst Funds Management opened a new position in Genelux (GNLX) in Q1 2026: 21,824 shares worth $52.8K. The stake represents 0.01% of the portfolio and ranks #538 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in GNLX as recently as Q1 2025.

Catalyst Funds Management first reported a position in GNLX in Q2 2024 and has held it in 4 quarters since. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Catalyst Funds Management held 21,824 shares of Genelux worth $52.8K as of Q1 2026.
  • Genelux was a new Catalyst Funds Management position in Q1 2026.
  • Genelux made up 0.01% of Catalyst Funds Management's portfolio in Q1 2026, its #538 holding.
  • Catalyst Funds Management first reported a position in Genelux in Q2 2024 and has held it in 4 quarters since.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.